Genespire strengthens its Board alongside Dr Julia Berretta as CEO and announces €16m Series A financing led by Sofinnova Partners

– ITALY, Milan –  Genespire, a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases, today announced the successful close of a €16M Series A financing from Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and Milan.…